Targeting and vaccine durability are key for populationlevel impact and costeffectiveness of a poxprotein HIV vaccine regimen in South Africa

Christian SelingerAnna BershteynDobromir DimitrovBlythe J.S AdamsonVera ReesGlenda GrayE et al2023-10-062023-10-06ISI0264-410Xhttps://hdl.handle.net/10539/36375Targeting and vaccine durability are key for populationlevel impact and costeffectiveness of a poxprotein HIV vaccine regimen in South Africa